Our Services
Our Brands
Appointment of New Distributor in Thailand
4 November 2019
The REPROCELL group has signed a non-exclusive distributorship agreement with A.N.H. Scientific Marketing Co. Ltd. to distribute REPROCELL’s products and services in Thailand.
Lantern Pharma Selects REPROCELL Inc. to Provide Preclinical Screening and Biomarker Discovery Services for Portfolio of Targeted Oncology Drugs
29 October 2019
Lantern Pharma announced today that it has selected REPROCELL to provide preclinical screening and drug sensitivity work for its portfolio of oncology drugs.
PRESS RELEASE: REPROCELL and NeuCyte enter distribution agreement in North America and Europe
25 September 2019
Yokohama, Japan, & San Carlos, California, USA — REPROCELL, Inc., and NeuCyte, Inc., today announced a new distributorship.
PRESS RELEASE: Axion BioSystems make REPROCELL a product distributor
28 August 2019
Axion BioSystems, Inc., the world leader in multi-well microelectrode array (MEA) systems, has announced REPROCELL as the new distributor of its Maestro systems and consumables in Japan.
PRESS RELEASE: ABLE Biott Bioreactors now available in Europe
22 August 2019
Glasgow, UK: REPROCELL Europe Ltd today announced exclusive distribution rights to a single-use reactor series for stem cell culture in 11 European countries.
See more REPROCELL Company News »
How to Characterize Stem Cells using Immunocytochemistry
2 December 2019
Planning ICC projects can be challenging as it requires careful selection of compatible antibodies, fluorochromes and blocking reagents.
How SynFire® Technology can benefit your research
26 November 2019
In celebration of our distributorship with NeuCyte, REPROCELL catches up with NeuCyte’s Head of Neuroscience, Dr Daniel Haag, to discuss the benefits of SynFire technology.
Stem cells offer hope for sufferers of Spinocerebellar Ataxia
8 November 2019
Spinocerebellar ataxias (SCAs) are a group of inherited, genetically heterogeneous disorders which are characterised by ocular motor abnormalities, cognitive dysfunction, peripheral neuropathy and progressive cerebellar ataxia.
How to mass culture iPSCs in suspension
30 October 2019
In order to fully realize the potential of iPSCs for many of the above applications, there is a requirement to generate a vast number of cells; hence, an effective method of mass culture of iPSCs is highly sought after by iPSC researchers.
Improve your gene-editing success with CRISPR-SNIPER technology
29 October 2019
The discovery of both CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and associated proteins, the Cas nucleases, has revolutionized the field of gene-editing.
Our Popular Products
